(Q33886379)

29 July 2017

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity (English)

1 reference

polycystic ovary syndrome

29 July 2017

0 references

1 reference

1 reference

1 reference

Mather KJ

1

1 reference

29 July 2017

Kwan F

series ordinal

2

1 reference

29 July 2017

Corenblum B

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 July 2017

Fertility and Sterility

1 reference

29 July 2017

73

1 reference

29 July 2017

150-156

1 reference

29 July 2017

1

1 reference

Polycystic ovary syndrome

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Insulin regulation of human ovarian androgens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Coronary heart disease risk factors in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Cardiovascular risk in women with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Abdominal adiposity and coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Prediction of Coronary Heart Disease Using Risk Factor Categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Mortality of women with polycystic ovary syndrome at long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Cardiac flow velocity in women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Metabolic aspects of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Dyslipoproteinemia and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Lack of linear relationship between hyperinsulinaemia and hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Obesity, lipids, cardiovascular risk, and androgen excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

Insulin and risk of cardiovascular disease: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900468-9

10.1016/S0015-0282(99)00468-9

7 January 2021

Identifiers

DOI

1 reference

release_om332kqp7zdepl7xmnixdyd7z4

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/om332kqp7zdepl7xmnixdyd7z4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference